MPO: Drug Delivery Implants – Advantages & Design Insights

abstract background
News & Press Releases

MPO: Drug Delivery Implants: Advantages & Design Insights

Drug delivery implants are changing how medication is administered by enabling site-specific, long-term therapeutic release. These systems offer a powerful alternative to traditional methods like oral or intravenous dosing, which often result in low bioavailability, poor patient adherence, and systemic side effects.

In a recent article for Medical Product Outsourcing, Gary Skarja, Bio Services Program Manager at StarFish Medical, discusses the advantages of drug delivery implants and shares design strategies that improve patient outcomes. He highlights how these systems deliver medication directly to the target tissue, enabling better control over dosing while reducing unwanted effects throughout the body.

Unlike traditional delivery approaches, these implants remain at the treatment site and release medication steadily over time. This method can eliminate the need for frequent dosing and helps maintain consistent drug levels. Common implantation sites include the brain, subcutaneous tissue, the bladder, and the cardiovascular system. The choice depends on the intended therapy, drug type, and duration.

Why Drug Delivery Implants Are Gaining Ground

Designing implantable drug delivery systems requires close attention to multiple factors. Biocompatibility is essential, as any materials that interact with tissue must be safe and not trigger an immune response. The drug’s release mechanism—whether by diffusion, degradation, or osmotic flow—must match the drug’s chemistry and therapeutic goal. Developers also consider implant size, ease of placement, and patient comfort.

Manufacturing processes are just as important. Cleanroom conditions, validated sterilization techniques, and regulatory compliance ensure safety and effectiveness. Since these products combine both drug and device components, meeting regulatory requirements for both is essential.

The future of these technologies looks promising. Innovations in biodegradable materials, smart polymers, and minimally invasive surgical tools are making drug delivery implants more efficient and easier to use. These advancements could expand their use in chronic disease management and personalized therapies.

About StarFish Medical

StarFish Medical provides award-winning design, development, commercialization, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Digital Health, Cardiovascular, Neurology, Urology, Gastroenterology, Otology, Ophthalmology, and In-Vitro Diagnostics.

StarFish Medical’s technical expertise includes electronics, mechanical, software/firmware systems engineering, in addition to industrial design and human factors. Regulatory Affairs (RA) and Quality Assurance (QA) consultants at StarFish Medical provide regulatory assistance for FDA, CE Mark and Health Canada submissions. Services include QA support for setting up QMS for start-up companies with implementation at the client’s site, and assisting with ISO 13485 certification audits..

Empowering Medtech Innovation®. www.starfishmedical.com

Contact Patrick Dean, Director of Marketing, for media inquiries.